Growth Metrics

Nuwellis (NUWE) Other Accumulated Expenses (2016 - 2026)

Nuwellis posted quarterly Other Accumulated Expenses of $71000.0 for Q1 2026, down 17.44% year-on-year from $86000.0 in Q1 2025, and down 16.47% on a QoQ basis from $85000.0 in Q4 2025.

Nuwellis (NUWE) has 11 years of Other Accumulated Expenses data on file, last reported at $71000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other Accumulated Expenses fell 17.44% year-over-year to $71000.0; the trailing twelve-month figure through Mar 2026 stood at $71000.0 (down 17.44% YoY), and the FY2025 full-year result was $85000.0, up 107.32% from the prior year.
  • Other Accumulated Expenses for Q1 2026 stood at $71000.0, down from $85000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $86000.0 in Q1 2025 and bottomed at $41000.0 in Q4 2024.
  • The 5-year median for Other Accumulated Expenses is $58000.0 (2022), against an average of $61058.8.
  • The widest annual swing landed in 2023, when Other Accumulated Expenses plunged 38.36%; it then soared 107.32% in 2025.
  • A 5-year view of Other Accumulated Expenses shows it stood at $58000.0 in 2022, then declined by 12.07% to $51000.0 in 2023, then dropped by 19.61% to $41000.0 in 2024, then jumped by 107.32% to $85000.0 in 2025, then fell by 16.47% to $71000.0 in 2026.
  • The last three Other Accumulated Expenses figures came in at $71000.0 (Q1 2026), $85000.0 (Q4 2025), and $76000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Nuwellis 1.45 Mn -630,292.49 1.68 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 71,000.00
Dec 31, 2025 85,000.00
Sep 30, 2025 76,000.00
Jun 30, 2025 74,000.00
Mar 31, 2025 86,000.00
Dec 31, 2024 41,000.00
Sep 30, 2024 50,000.00
Jun 30, 2024 56,000.00
Mar 31, 2024 45,000.00
Dec 31, 2023 51,000.00
Sep 30, 2023 45,000.00
Jun 30, 2023 60,000.00
Mar 31, 2023 49,000.00
Dec 31, 2022 58,000.00
Sep 30, 2022 73,000.00
Jun 30, 2022 63,000.00
Mar 31, 2022 55,000.00
Dec 31, 2021 36,000.00
Sep 30, 2021 38,000.00
Jun 30, 2021 54,000.00
Mar 31, 2021 69,000.00
Dec 31, 2020 66,000.00
Sep 30, 2020 57,000.00
Jun 30, 2020 40,000.00
Mar 31, 2020 39,000.00
Dec 31, 2019 85,000.00
Sep 30, 2019 87,000.00
Jun 30, 2019 97,000.00
Mar 31, 2019 228,000.00
Dec 31, 2018 209,000.00
Sep 30, 2018 80,000.00
Jun 30, 2018 186,000.00
Mar 31, 2018 198,000.00
Dec 31, 2017 208,000.00
Dec 31, 2016 364,000.00